Påverkan på PK(INR)-värdet efter olika preanalytiska behandlingar i venöst humanblod.
Independent thesis Basic level (degree of Bachelor), 10 credits / 15 HE creditsStudent thesis
Venous thromboembolism that cause blood clotting in blood vessels, prevent blood circulation, depending on changes in one or more of the coagulation factors II, VII, IX and X. Patients who have had a blood clot or cardiovascular diseases are treated with oral anti-vitamin K (Warfarin®) to reducing and prevent relapse. Warfarin is also used as a preventive treatment before the disease. An overdose of Warfarin® may cause bleeding-complications and low dose cause blood clotting. The dosage of the drug is controlled by measuring prothrombin in plasma. The aim of this study was to investigate if prothrombin-complex value changes due to re-spinning and re-analysis after six hours. Fitty whole blood samples from warfarin-treated patients were divided into three subgroups, those with protrombinkomplex-values of 2-4 (n=20), >4 (n=15) and <2 (n=15). The samples were centrifugated and measured (Method A), re-centrifugated and measured (Method B) or re-analysed after six hours (Method C). All results were compared in a Bland-Altman plot as follows: Method B vs. Method A and Method C vs. Method A. The scatter graph yielded a strong correlation between Method A and Method B (R2=0.9984) and Method A and Methods C (R2=0.9977). The results from t-test showed a significance level (p<0.001) for both analyses (statistical significance=p<0.05). In this study we showed that prothrombin complex value ware stable after re-centrifugation and re-measurement after six hours. Statistical calculations yielded a strong correlation between the methods (A, B, C), and there was no significance difference between the methods.
Place, publisher, year, edition, pages
2015. , 22 p.
Venous thromboembolism, prothrombin complex, Warfarin®, anti-vitamin K, re-spin, blood clotting, coagulation factors
Venös tromboembolism, protrombinkomplex, antivitamin-K, waran, återcentrifugering, blodproppar, koagulationsfaktorer
Medicinal Chemistry Biomedical Laboratory Science/Technology
IdentifiersURN: urn:nbn:se:hkr:diva-15316OAI: oai:DiVA.org:hkr-15316DiVA: diva2:909966
Bachelor of Science in Biomedical Laboratory Science